HealthcareThursday, May 21, 2026· 2 min read

The Path’s AI Therapy Scores 95 on Vera‑MH, Raising Safety Bar for Digital Mental Health

TL;DR

The Path, founded by Tony Robbins and former Calm leaders, says its AI therapy model scored an impressive 95 on the Vera‑MH mental health safety benchmark — far above the 65 top score of consumer bots. This milestone suggests more trustworthy, safer AI support for people seeking mental health help and could accelerate adoption and oversight of clinical-grade digital therapy tools.

Key Takeaways

  • 1The Path’s AI model scored a near-leading <strong>95</strong> on the Vera‑MH safety benchmark, compared with a top consumer-bot score of <strong>65</strong>.
  • 2Founded by Tony Robbins and Calm alums, The Path is positioning its product around safety and clinical responsibility.
  • 3High safety performance could reduce harm, build user trust, and support smoother regulatory and clinical integration.
  • 4This result highlights the role of targeted benchmarks like Vera‑MH in measuring and improving therapeutic AI behavior.

The Path’s AI Therapy Scores 95 on Vera‑MH, Raising Safety Bar for Digital Mental Health

The Path, a startup founded by Tony Robbins alongside alumni from Calm, reported that its AI therapy model achieved a score of 95 on Vera‑MH, a specialized mental health safety benchmark. That performance stands out against consumer-focused chatbots, which top out around a score of 65, and signals a meaningful advance in building AI that responsibly supports people in distress.

The high Vera‑MH score reflects The Path’s emphasis on safety-first design: constrained responses, escalation pathways to human clinicians, and guardrails tuned to reduce risky or inappropriate advice. For users, that translates into a clearer separation between supportive coaching and clinical interventions, and faster routes to human help when needed.

Why it matters: Safer AI therapy can broaden access to mental health support while lowering the risk of harm from automated systems. Benchmarks like Vera‑MH give developers, clinicians, and regulators a common yardstick to compare systems and prioritize improvements. A jump from mid-60s to the mid-90s is the kind of measurable progress that can increase trust among clinicians and users alike.

  • The Path’s founders combine behavioral expertise and consumer mental health experience, aligning product design with real-world care pathways.
  • High benchmark scores help justify pilot programs, clinical trials, and partnerships with healthcare providers.
  • Transparent safety testing encourages other companies to adopt stronger guardrails and benchmarking practices.

While widespread clinical deployment still requires ongoing validation and regulatory alignment, The Path’s Vera‑MH result is an encouraging sign that AI can be engineered to meet the safer, more reliable standards mental health care demands. This development points toward a future where digital tools complement human clinicians, expanding access while maintaining high safety standards.

Get AI Wins in Your Inbox

The best positive AI stories delivered to your inbox. No spam, unsubscribe anytime.